DK0858804T3 - Anvendelse af rifaximin og farmaceutiske præparater indeholdende dette i behandlingen af diarré forårsaget af cryptosporidiosis - Google Patents
Anvendelse af rifaximin og farmaceutiske præparater indeholdende dette i behandlingen af diarré forårsaget af cryptosporidiosisInfo
- Publication number
- DK0858804T3 DK0858804T3 DK98101081T DK98101081T DK0858804T3 DK 0858804 T3 DK0858804 T3 DK 0858804T3 DK 98101081 T DK98101081 T DK 98101081T DK 98101081 T DK98101081 T DK 98101081T DK 0858804 T3 DK0858804 T3 DK 0858804T3
- Authority
- DK
- Denmark
- Prior art keywords
- cryptosporidiosis
- rifaximin
- treatment
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97BO000064A IT1290679B1 (it) | 1997-02-14 | 1997-02-14 | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0858804T3 true DK0858804T3 (da) | 2002-07-08 |
Family
ID=11341939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98101081T DK0858804T3 (da) | 1997-02-14 | 1998-01-22 | Anvendelse af rifaximin og farmaceutiske præparater indeholdende dette i behandlingen af diarré forårsaget af cryptosporidiosis |
Country Status (12)
Country | Link |
---|---|
US (1) | US5886002A (hu) |
EP (1) | EP0858804B1 (hu) |
JP (1) | JP4848083B2 (hu) |
KR (1) | KR100436243B1 (hu) |
CN (1) | CN1115146C (hu) |
AT (1) | ATE218342T1 (hu) |
DE (1) | DE69805672T2 (hu) |
DK (1) | DK0858804T3 (hu) |
ES (1) | ES2178048T3 (hu) |
HU (1) | HU224592B1 (hu) |
IT (1) | IT1290679B1 (hu) |
PT (1) | PT858804E (hu) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
KR20060006953A (ko) * | 2003-04-30 | 2006-01-20 | 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 | 치환된 카르복실산 |
US8003118B2 (en) * | 2005-03-02 | 2011-08-23 | Kodsi Robert E | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
US20060210483A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
US20060210492A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Use of rifaximin for treatment and prevention of periodontal conditions |
ES2522895T3 (es) | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
AU2007281413B2 (en) * | 2006-08-02 | 2013-10-31 | Christopher Jahraus | Compositions and methods for the treatment of radiation proctosigmoiditis |
US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
DK2327407T3 (da) * | 2008-09-26 | 2014-08-25 | Aska Pharm Co Ltd | Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme |
PL2350096T3 (pl) | 2008-10-02 | 2020-06-29 | Salix Pharmaceuticals, Ltd. | Sposoby leczenia encefalopatii wątrobowej |
US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
JP2013511570A (ja) | 2009-11-23 | 2013-04-04 | シプラ・リミテッド | 局所用泡沫組成物 |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
AU2011225810B2 (en) * | 2010-03-10 | 2014-11-06 | Lupin Limited | Rifaximin ready-to-use suspension |
AU2011303715A1 (en) | 2010-09-13 | 2013-04-04 | Cipla Limited | Pharmaceutical composition |
WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
EP2927235B1 (en) | 2014-03-31 | 2017-02-08 | Euticals S.P.A. | Polymorphic mixture of rifaximin and its use for the preparation of solid formulations |
ES2810010T3 (es) | 2014-05-12 | 2021-03-08 | Alfasigma Spa | Preparación y uso de la forma cristalina tau de rifaximina solvatada con DEGME |
MX2016016458A (es) * | 2014-06-30 | 2017-07-13 | Salix Pharmaceuticals Inc | Métodos para repetir tratamiento de síndrome del intestino irritable (ibs). |
WO2016138118A1 (en) * | 2015-02-26 | 2016-09-01 | Jaguar Animal Health, Inc. | Use of croton- or calophyllum-derived proanthocyanidin polymers or botanical extracts in combination with rifaximin for the treatment of diarrhea in non-human animals |
JP6817966B2 (ja) * | 2015-06-10 | 2021-01-20 | シンロジック オペレーティング カンパニー インコーポレイテッド | 高アンモニア血症に関連する疾患を治療するために操作された細菌 |
EP3525825B1 (en) | 2016-10-14 | 2024-03-20 | Cipla Limited | Pharmaceutical compositions comprising rifaximin |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264494B1 (it) * | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
-
1997
- 1997-02-14 IT IT97BO000064A patent/IT1290679B1/it active IP Right Grant
-
1998
- 1998-01-22 DE DE69805672T patent/DE69805672T2/de not_active Expired - Lifetime
- 1998-01-22 HU HU9800115A patent/HU224592B1/hu active IP Right Grant
- 1998-01-22 ES ES98101081T patent/ES2178048T3/es not_active Expired - Lifetime
- 1998-01-22 DK DK98101081T patent/DK0858804T3/da active
- 1998-01-22 AT AT98101081T patent/ATE218342T1/de active
- 1998-01-22 PT PT98101081T patent/PT858804E/pt unknown
- 1998-01-22 EP EP98101081A patent/EP0858804B1/en not_active Expired - Lifetime
- 1998-01-26 US US09/013,655 patent/US5886002A/en not_active Expired - Lifetime
- 1998-02-12 JP JP02981398A patent/JP4848083B2/ja not_active Expired - Lifetime
- 1998-02-13 KR KR10-1998-0004389A patent/KR100436243B1/ko not_active IP Right Cessation
- 1998-02-13 CN CN98106920A patent/CN1115146C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0858804A1 (en) | 1998-08-19 |
PT858804E (pt) | 2002-10-31 |
ITBO970064A1 (it) | 1998-08-14 |
JPH10226645A (ja) | 1998-08-25 |
IT1290679B1 (it) | 1998-12-10 |
CN1214244A (zh) | 1999-04-21 |
HU9800115D0 (en) | 1998-03-30 |
CN1115146C (zh) | 2003-07-23 |
HU224592B1 (hu) | 2005-11-28 |
KR19980071348A (ko) | 1998-10-26 |
DE69805672D1 (de) | 2002-07-11 |
HUP9800115A3 (en) | 2000-04-28 |
ATE218342T1 (de) | 2002-06-15 |
US5886002A (en) | 1999-03-23 |
HUP9800115A1 (hu) | 1999-06-28 |
ITBO970064A0 (it) | 1997-02-14 |
JP4848083B2 (ja) | 2011-12-28 |
ES2178048T3 (es) | 2002-12-16 |
KR100436243B1 (ko) | 2004-08-25 |
DE69805672T2 (de) | 2003-01-23 |
EP0858804B1 (en) | 2002-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0858804T3 (da) | Anvendelse af rifaximin og farmaceutiske præparater indeholdende dette i behandlingen af diarré forårsaget af cryptosporidiosis | |
DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
CO4340622A1 (es) | Nuevos macrociclos bis-indolil maleimida | |
TR200101567T2 (tr) | Yeni triazolo(4.5-D)pirimidin bileşimleri. | |
EA200200208A1 (ru) | Синергитическая композиция | |
TR200000197T2 (tr) | Yeni bileşimler | |
ATE217629T1 (de) | Phosphonooxymethyl oder methylthiomethylether von taxanderivaten als antitumormittel | |
DE60227492D1 (de) | Hemmstoffe der akt aktivität | |
FI933565A0 (fi) | 7-(substituerad)-9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner | |
HK1026691A1 (en) | Substituted benzimidazoles and their use for treating retroviral infection | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
BR0014381A (pt) | Derivados de 5-beta-sapogenina e pseudossapogenina e seu uso no tratamento de demência | |
TR200100448T2 (tr) | Fenil ksantin türevleri | |
TR200000152T2 (tr) | Yeni bileşikler. | |
EP1453505A4 (en) | USE OF PRAMIPEXOLE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | |
HUP0300534A2 (hu) | Tumorellenes ekteinaszcidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
NZ504487A (en) | Combination of alpha-adrenergic antagonists and cGMP elevators for the treatment of impotence | |
TNSN99001A1 (fr) | Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques | |
DE69814135D1 (de) | 7-substituierte chinazolin-2,4-dionen verwendbar als antibakterielle mittel | |
BG105256A (en) | Muscarinic agonists and antagonists | |
TR200000907T2 (tr) | Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. | |
GB2380939B (en) | Treatment or prevention of auto-immune diseases | |
TR200101493T2 (tr) | Eletriptan hidrobromid monohidrat | |
HUP0002836A2 (hu) | Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
ITRM920305A0 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. |